Keefe, Bruyette & Woods maintains Jack Henry & Associates at Outperform, raises price target to $215 from $200

Keefe, Bruyette & Woods reaffirmed its Outperform rating for Jack Henry & Associates and increased its price target to $215 from $200, suggesting a 20% upside from the Nov 4 close of $179.16.

Original reporting
Published Nov 5, 2026, 6:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 6:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Keefe, Bruyette & Woods maintains Jack Henry & Associates at Outperform, raises price target to $215 from $200 — source image
Decision brief

The 30-second read

$JKHYBullishMed
01

Why it matters

The higher target may prompt short covering and new buying, modestly boosting the stock.

02

Market read

Analyst rating change provides a fresh catalyst for JKHY, offering a modest trading edge.

03

What to watch

Potential competition from cloud‑based fintech platforms not addressed in the note.

Relevance 7/10Novelty 6/10Timing: pre‑market today

Background

Analyst coverage update from Keefe, Bruyette & Woods on Jack Henry & Associates.

Company-level read

Ticker impact

$JKHYBullishHigh confidence
Context

Keefe, Bruyette & Woods maintained Outperform on Jack Henry & Associates and raised its price target to $215 from $200.

Expected impact

likely upward pressure as investors price in the new $215 target.

Evidence & confidence

Target increase reflects improved earnings outlook and may attract buying interest.

Market effects

May lift sentiment for the financial software sector.

Limited to U.S. equities, primarily the fintech niche.

Low global relevance beyond niche investors.

Counterpoint

Target raise could be premature if macro pressures curb banking software spending.

Key entities

  • Jack Henry & Associates

    Provider of technology solutions for banks and credit unions.

  • Keefe, Bruyette & Woods

    Equity research firm that issued the rating.

Related articles

$JKHYMed

Jack Henry & Associates Inc (JKHY) (Q1 2027) Earnings Call Highlights: Record

Jack Henry & Associates (JKHY) reported Q1 2027 revenue growth deceleration to 5% and operating margin contraction. The company reiterated non-GAAP margin expansion guidance of 20-40 basis points, citing headwinds from medical costs and cybersecurity investments. R&D expenses rose 17% GAAP, pressuring margins. Management discussed growth levers, including payments strength, cloud adoption, and fraud prevention. Core wins remain strong, but near-term growth trends may be uneven.

$JKHYHighAI 8/10

Jack Henry (JKHY) Q1 2027 Earnings Call Transcript

Jack Henry (JKHY) reported Q1 2027 earnings exceeding expectations, with 28% non-GAAP operating margin, up 102 basis points YoY. The company secured nine competitive core wins, double the prior year, and saw strong client engagement at its largest-ever conference. Key growth areas include Gladiator security solutions, AI-enabled products, and Tap2Local merchant payments. The company remains optimistic about its fiscal year 2027 outlook.

$JKHYMedAI 8/10

Jack Henry & Associates Q1 Earnings Call Highlights

Jack Henry & Associates (JKHY) reported Q1 revenue growth in cloud services (11%) and payments (11%), with recurring revenue at 93%. Demand for cybersecurity and AI products increased, with 367 Gladiator solutions sold. The company expects to launch more AI offerings and consulting services. Transaction volumes for Zelle, RTP, and FedNow rose 42% YoY. Non-GAAP margins improved, with operating cash flow up 34% to $161M. JKHY reaffirmed its full-year margin expansion and free-cash-flow outlook.